Author:
Lewis Julia B.,Sika Mohammed,Koury Mark J.,Chuang Peale,Schulman Gerald,Smith Mark T.,Whittier Frederick C.,Linfert Douglas R.,Galphin Claude M.,Athreya Balaji P.,Nossuli A. Kaldun Kaldun,Chang Ingrid J.,Blumenthal Samuel S.,Manley John,Zeig Steven,Kant Kotagal S.,Olivero Juan Jose,Greene Tom,Dwyer Jamie P.
Publisher
American Society of Nephrology (ASN)
Subject
Nephrology,General Medicine
Reference34 articles.
1. Hyperphosphatemia: Its Consequences and Treatment in Patients With Chronic Renal Disease
2. Serum Phosphorus Levels Associate with Coronary Atherosclerosis in Young Adults
3. Umanath K, Blumenthal SS, Koury M, Sika M, Greco BA, Jalal DI, Reisin E, Manley J, Zeig S, Negoi DG, Hiremath AN, Lewis JB, Dwyer JP, for the Collaborative Study Group: Ferric citrate as a phosphate binder reduces IV iron and erythropoiesis stimulating agent (ESA) use. Presented at the American Society of Nephrology Kidney Week, Atlanta, GA, November 7, 2013
4. Dose-Response and Efficacy of Ferric Citrate to Treat Hyperphosphatemia in Hemodialysis Patients: A Short-term Randomized Trial
5. New phosphate binding agents: Ferric compounds.;Hsu;J Am Soc Nephrol,1999
Cited by
168 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献